Parkinson's disease (PD) is an age-related neurodegenerative disorder characterized by resting tremor, rigidity and bradykinesia. These clinical features are thought to arise from reduced dopaminergic input to the striatum, which is caused by the degeneration of dopaminergic neurons in the substantia nigra. The occurrence of PD is largely sporadic, but clinical syndromes resembling sporadic PD can also be caused by mutations in the asynuclein, parkin, DJ-1 and PINK1 genes. Elucidation of the pathogenic mechanisms underlying the selective dopaminergic degeneration in familial parkinsonism will likely provide important clues to the pathogenic mechanisms responsible for idiopathic PD. The recent identification of the parkinsonian genes made it possible to investigate the underlying pathogenic mechanism by employing genetic approaches. The central hypothesis underlying our research is that the familial parkinsonism-linked mutations alter the normal physiology of dopaminergic neurons in the substantia nigra, ultimately leading to the degeneration of dopaminergic neurons and the production of motor impairments. Our previous generation and analysis of parkin-/- mice have shown nigrostriatal deficits and mitochondrial dysfunction in the absence of loss of dopaminergic neurons, suggesting that these dopaminergic functional deficits likely precede neurodegeneration, and that mitochondrial dysfunction may be causal in PD pathogenesis. In this proposal, we hypothesize that loss-of-function mutations in the DJ-1 gene alter the normal physiology of dopaminergic neurons, and that the presence of multiple pathogenic mutations accelerates dopaminergic dysfunction and degeneration, leading to progressive loss of dopaminergic neurons in mice. To test these hypotheses, we propose the following Specific Aims. First, we will generate and analyze DJ-1-null mice for disruption of normal dopaminergic neurotransmission, loss of dopaminergic neurons and motor impairments. Second, we will determine whether loss of DJ-1 function results in mitochondrial dysfunction and increased oxidative damage. Third, since mouse models bearing mutations in a single pathogenic gene, such as parkin-null and alpha-synuclein transgenic mice, fail to develop the cardinal future of PD, namely selective dopaminergic degeneration, we will investigate whether the presence of multiple pathogenic mutations (alpha-synuclein Tg;parkin-/-;DJ-1-/-) accelerates the dysfunction and degeneration of dopaminergic neurons in triple mutant mice. Our long-term goal is to develop a genetic mouse model that recapitulates all central features of PD and to characterize the molecular pathways responsible for PD pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS038375-10
Application #
7932142
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
10
Fiscal Year
2009
Total Cost
$543,008
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Bartels, Tim; Choi, Joanna G; Selkoe, Dennis J (2011) ýý-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107-10
Shtifman, Alexander; Zhong, Nan; Lopez, Jose R et al. (2011) Altered Ca2+ homeostasis in the skeletal muscle of DJ-1 null mice. Neurobiol Aging 32:125-32
Vamvaca, Katherina; Lansbury Jr, Peter T; Stefanis, Leonidas (2011) N-terminal deletion does not affect ýý-synuclein membrane binding, self-association and toxicity in human neuroblastoma cells, unlike yeast. J Neurochem 119:389-97
Berger, Zdenek; Smith, Kelsey A; Lavoie, Matthew J (2010) Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation. Biochemistry 49:5511-23
Giaime, E; Sunyach, C; Druon, C et al. (2010) Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6. Cell Death Differ 17:158-69
Logan, Todd; Clark, Lindsay; Ray, Soumya S (2010) Engineered disulfide bonds restore chaperone-like function of DJ-1 mutants linked to familial Parkinson's disease. Biochemistry 49:5624-33
Tong, Youren; Shen, Jie (2009) alpha-synuclein and LRRK2: partners in crime. Neuron 64:771-3
da Costa, Cristine Alves; Sunyach, Claire; Giaime, Emilie et al. (2009) Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat Cell Biol 11:1370-5
Rappley, Irit; Gitler, Aaron D; Selvy, Paige E et al. (2009) Evidence that alpha-synuclein does not inhibit phospholipase D. Biochemistry 48:1077-83
Cronin, Kenneth D; Ge, Dongliang; Manninger, Paul et al. (2009) Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain. Hum Mol Genet 18:3274-85

Showing the most recent 10 out of 41 publications